To further determine the effects of dual PI3Kγ/PD-L1 inhibition on myeloid cells, which potentially contribute to reduced tumor growth in HNSCC tumor-bearing mice, we examined how macrophage phenotypes may impact the immune response to tumors following dual PI3Kγ/PD-L1 treatment. The gene discussed is CD274; the disease is head and neck squamous cell carcinoma.